Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes

NCT00106340 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3118

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: vildagliptin
DRUG: glimepiride
DRUG: Metformin
DRUG: Vildagliptin matching placebo
DRUG: Glimepiride matching placebo

Sponsor

Novartis Pharmaceuticals